The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has put out a call for developers of artificial intelligence as a medical device (AIaMD) technology to join its new regulatory ...

Along with AI-Airlock, the MHRA is also working on two new guidance documents, called Good machine learning practice for medical device deployment and Best practice AIaMD development and ...

The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer of the Medicines and ...

First Global Regulatory Approval of PrecivityAD2 for Use as an In-Vitro Diagnostic to Aid in the Diagnosis of Alzheimer’s Disease The PrecivityAD2 blood test is an analytically and clinically ...

Reading from an email sent by Graeme Tunbridge, director of devices at the MHRA in March 2020, counsel to the inquiry Richard Wald KC said: “CDL was keen to press forward with Dyson’s proposal to a ...

today announced the medical device registration from the United Kingdom’s Medicines and Healthcare products Regulatory Agency (UK MHRA) for the PrecivityAD2 ™ blood test.